Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term prognostic-significance. Found 10 abstracts

O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Goorha S, Lancet J, Maness LJ, Marcucci G, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Tallman MS, Wang ES, Naganuma M, Gregory KM. Acute Myeloid Leukemia Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2012 Aug;10(8):984-1021.   PMCID: not NIH funded
Lara JF, Thor AD, Dressler LG, Broadwater G, Bleiweiss IJ, Edgerton S, Cowan D, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA, Hayes DF, Canc Leukemia Grp B. p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905). Clinical Cancer Research. 2011 Aug;17(15):5170-8.   PMCID: PMC319770
Boorjian SA, Karnes RJ, Crispen PL, Carlson RE, Rangel LJ, Bergstralh EJ, Blute ML. The Impact of Positive Surgical Margins on Mortality Following Radical Prostatectomy During the Prostate Specific Antigen Era. Journal of Urology. 2010 Mar;183(3):1003-9.   PMCID: *
Boorjian SA, Blute ML. Surgery for vena caval tumor extension in renal cancer. Current opinion in urology. 2009 Sep;19(5):473-7.
Khor LY, DeSilvio M, Li RL, McDonnell TJ, Hammond ME, Sause WT, Pilepich MV, Okunieff P, Sandler HM, Pollack A. Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Sep;66(1):25-30.
Nam JS, Kang MJ, Suchar AM, Shimamura T, Kohn EA, Michalowska AM, Jordan VC, Hirohashi S, Wakefield LM. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. CANCER RESEARCH. 2006 Jul;66(14):7176-84.
Schor AP, Carvalho FM, Kemp C, Silva I, Russo J. S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncology reports. 2006 Jan;15(1):3-6.
Freedman GM, Anderson PR, Hanlon AL, Eisenberg DF, Nicolaou N. Pattern of local recurrence after conservative surgery and whole-breast irradiation. International Journal of Radiation Oncology Biology Physics. 2005 Apr;61(5):1328-36.
Agus DB, Bunn PA, Franklin W, Garcia M, Ozols RF. HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer. Seminars in Oncology. 2000 Dec;27(6):53-63.
Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer. Acta Oncologica. 1999 Jan;38:9-17.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term prognostic-significance

prognostic-significance therapy randomized clinical-trial postoperative radiotherapy local recurrence Oncology carcinoma comparing total mastectomy risk salvage radiotherapy bax conventional care tp53 mutation radiation-therapy mastectomy in-situ hybridization identification breast radiation venous tumor thrombus distant metastases kidney transplantation gene amplification status adjuvant radiotherapy bcl-2 retropubic prostatectomy favorable stem-cell 1st complete remission epithelial-cells androgen immunohistochemical analysis estrogen receptor human-breast breast cancer Bcl-2 in-vivo regimens targeted resistance kidney cancer pathological findings adjuvant chemotherapy renal cell carcinoma radiation- high-dose cytarabine adhesion system salvage conservative surgery Nuclear Medicine & Medical Imaging Radiology predictive-value thrombus extension conserving therapy cancer risk p53 genes S100P biochemical recurrence core-binding-factor growth-factor receptor survival multivariate-analysis internal tandem duplication link na+ vein human tyrosine institut-gustave-roussy radical prostatectomy prostatectomy prostatic neoplasms-prostate-specific antigen k+-atpase radical nephrectomy monocyte chemoattractant protein-1 apoptosis xenograft models tumor-suppressor gene gene expression breast proliferative lesions acute promyelocytic leukemia kinase family androgen deprivation ki-67 calcium-binding protein e-cadherin acute myelogenous leukemia nephrectomy c-myc consecutive patients myelodysplastic syndrome nf-kappa-b clinical-significance circulatory arrest neoadjuvant hormonal-therapy poor-prognosis estrogen-receptor cell carcinoma thrombectomy radiation therapy tumor recurrence estrogen-receptor-alpha 20-year follow-up cancer recurrence axillary dissection androgen ablation surgical-management systemic therapy biopsies
Last updated on Wednesday, February 05, 2020